| Date Filed | Type | Description |
| 07/06/2023 |
4/A
| Zanganeh Mahkam (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised (in-or-at-the-money) 86,668 warrants
@ $2.05, valued at
$177.7k
|
|
| 06/06/2023 |
4
| Zanganeh Mahkam (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.95, valued at
$119k
Granted 20,168 options to buy
@ $5.95, valued at
$120k
|
|
| 03/13/2023 |
4/A
| Zanganeh Mahkam (Co-CEO & President) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 16,778,415 shares
@ $1.05, valued at
$17.6M
Bought 6,748,629 shares
@ $1.05, valued at
$7.1M
|
|
| 03/13/2023 |
SC 13D/A
| Zanganeh Mahkam reports a 5.3% stake in Summit Therapeutics Inc. |
| 03/08/2023 |
4
| Zanganeh Mahkam (Co-CEO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 15,973,743 shares
@ $1.05, valued at
$16.8M
Bought 804,672 shares
@ $1.05, valued at
$844.9k
Bought 6,748,629 shares
@ $1.05, valued at
$7.1M
|
|
| 12/09/2022 |
4
| Zanganeh Mahkam (Co-CEO & President) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Acquired 373,857 shares
@ $0 |
|
| 08/18/2022 |
4
| Zanganeh Maky (Co-CEO & President) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 184,430 shares
@ $0.97, valued at
$178.9k
Bought 4,593,777 shares
@ $0.97, valued at
$4.5M
Bought 1,030,925 shares
@ $0.97, valued at
$1000k
|
|
| 06/10/2022 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised (in-or-at-the-money) 86,668 shares
@ $0
Bought 86,668 warrants
@ $0 |
|
| 05/23/2022 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.14, valued at
$42.8k
Granted 56,075 options to buy
@ $2.14, valued at
$120k
|
|
| 12/17/2021 |
4
| Zanganeh Maky (COO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $4.75, valued at
$71.3k
|
|
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2021 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised (in-or-at-the-money) 3,000 warrants
@ $7.01, valued at
$21k
Exercised (in-or-at-the-money) 307 warrants
@ $7.01, valued at
$2.2k
|
|
| 11/25/2020 |
SC 13D/A
| Zanganeh Maky reports a 6.6% stake in Summit Therapeutics Inc. |
| 11/24/2020 |
4
| Zanganeh Maky (COO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 2,400,000 options to buy
@ $4.4, valued at
$10.6M
|
|
| 11/13/2020 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 200,000 options to buy
@ $3.71, valued at
$742k
Granted 3,323 options to buy
@ $3.71, valued at
$12.3k
|
|
| 11/13/2020 |
3
| Zanganeh Maky (Director) has filed a Form 3 on Summit Therapeutics Inc. |
| 11/10/2020 |
SC 13D/A
| Zanganeh Maky reports a 6.6% stake in Summit Therapeutics Inc. |
| 09/28/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2020 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $10.66, valued at
$213.2k
Granted 14,071 options to buy
@ $10.66, valued at
$150k
|
|
| 01/23/2020 |
SC 13D
| Zanganeh Maky reports a 7.1% stake in Summit Therapeutics, PLC |
| 05/17/2019 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 15,000 options to buy
@ $13.03, valued at
$195.5k
Granted 9,210 options to buy
@ $13.03, valued at
$120k
|
|
| 01/09/2019 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 2,364 options to buy
@ $13.22, valued at
$31.3k
|
|
| 05/24/2018 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 15,000 options to buy
@ $15.27, valued at
$229.1k
|
|
| 03/28/2018 |
5
| Zanganeh Maky (Director) has filed a Form 5 on Pulse Biosciences, Inc. |
| 03/28/2018 |
3/A
| Zanganeh Maky (Director) has filed a Form 3/A on Pulse Biosciences, Inc. |
| 12/15/2017 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Pulse Biosciences, Inc. |
| 12/13/2017 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Pulse Biosciences, Inc. |
| 11/06/2017 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Pulse Biosciences, Inc. |
| 09/18/2017 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Bought 13,000 shares
@ $12.2263, valued at
$158.9k
Bought 9,000 shares
@ $13.5486, valued at
$121.9k
Bought 7,775 shares
@ $15.0213, valued at
$116.8k
|
|
| 08/04/2017 |
4
| Zanganeh Maky (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Bought 8,290 shares
@ $25.147, valued at
$208.5k
Bought 6,000 shares
@ $23.227, valued at
$139.4k
Bought 9,500 shares
@ $23.89, valued at
$227k
Bought 5,000 shares
@ $23.003, valued at
$115k
|
|
|